Early Stratification Study of Acute Arthritis to Improve Diagnosis and Treatment

What this Trial Is About

Researchers are conducting the Early STratification of acute inflammatory ARThritis START study, a prospective observational study focused on early-stage inflammatory arthritis. The study aims to identify markers that can help with early diagnosis and personalized treatment of various inflammatory joint conditions. It addresses the challenge of managing early arthritis by using advanced methods to better understand the disease and improve patient care. The project is sponsored by Diakonhjemmet Hospital. The study does not involve any treatment or intervention. Instead, it collects extensive data from participants using modern imaging techniques, analyses of synovial fluid and biopsies, and studies of genetic, epigenetic, proteomic, microbiota, and immunological markers. This comprehensive approach seeks to build a platform to identify and validate biomarkers for better stratification of early inflammatory arthritis. Participants will be followed for 12 months to determine the final diagnosis. During this time, researchers will gather clinical data and conduct multiple assessments to monitor disease progression and biomarker relevance. The goal is to provide clinicians with improved tools for timely diagnosis and personalized care decisions. The total duration of participation spans at least one year, with regular evaluations to support study outcomes.

Early STratification of Acute ARThritis